Inhalation

INH0223

Issue link: https://www.e-digitaleditions.com/i/1491587

Contents of this Issue

Navigation

Page 0 of 40

The cover photo shows a dry powder inhaler with a hypromellose-origin capsule, specifically developed for inhaled drug delivery. Courtesy of Qualicaps®, Avenida Monte Valdelatas, 4, 28108 Madrid, Spain. Tel: +34 916 630 800, www.qualicaps.com Vo l u m e 1 7 N u m b e r 1 Fe b r u a ry 2 0 2 3 Inhalation CLICK HERE TO RENEW TODAY! Application of biological models to inform research and development of inhalation products Excipient enhanced growth (EEG): Expanding delivery options for treatment of lung diseases Cross-industry organizations: An update from ISAM Back pages: Slow adoption for peanut allergy drug and A food allergy bravery clinic Previewing RDD® Europe 2023

Articles in this issue

Links on this page

view archives of Inhalation - INH0223